<!DOCTYPE html><html><head><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width,initial-scale=1"><title>Medicamentalia</title><meta name="description" content="A journalistic investigation into access to medicines around the world"><meta property="fb:app_id" content="620090684758872"><meta property="og:title" content="Medicamentalia"><meta property="og:url" content="http://mola.medicamentalia.org"><meta property="og:image" content="/dist/images/medicamentalia-img.jpg"><meta property="og:site_name" content="Medicamentalia"><meta property="og:description" content="A journalistic investigation into access to medicines around the world"><link rel="apple-touch-icon" sizes="57x57" href="/assets/images/favicons/apple-icon-57x57.png"><link rel="apple-touch-icon" sizes="60x60" href="/assets/images/favicons/apple-icon-60x60.png"><link rel="apple-touch-icon" sizes="72x72" href="/assets/images/favicons/apple-icon-72x72.png"><link rel="apple-touch-icon" sizes="76x76" href="/assets/images/favicons/apple-icon-76x76.png"><link rel="apple-touch-icon" sizes="114x114" href="/assets/images/favicons/apple-icon-114x114.png"><link rel="apple-touch-icon" sizes="120x120" href="/assets/images/favicons/apple-icon-120x120.png"><link rel="apple-touch-icon" sizes="144x144" href="/assets/images/favicons/apple-icon-144x144.png"><link rel="apple-touch-icon" sizes="152x152" href="/assets/images/favicons/apple-icon-152x152.png"><link rel="apple-touch-icon" sizes="180x180" href="/assets/images/favicons/apple-icon-180x180.png"><link rel="icon" type="image/png" sizes="192x192" href="/assets/images/favicons/android-icon-192x192.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/images/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="96x96" href="/assets/images/favicons/favicon-96x96.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/images/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/images/favicons/manifest.json"><link rel="stylesheet" href="/assets/styles/main.css"><link rel="canonical" href="http://mola.medicamentalia.org/access/"><link rel="alternate" type="application/rss+xml" title="Medicamentalia" href="http://mola.medicamentalia.org/feed.xml"></head><body class="access lang-en" data-baseurl="http://mola.medicamentalia.org"><nav id="top" class="navbar navbar-default"><div class="container-fluid"><div class="navbar-header"><button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#main-menu"><span class="sr-only">Toggle navigation</span> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span></button> <a class="navbar-brand" href="/" title="Medicamentalia"><h1>Medicamentalia</h1></a></div><div id="main-menu" class="collapse navbar-collapse"><ul id="menu-main-menu" class="nav navbar-nav navbar-right"><li id="language-selector" class="menu-item menu-item-language"><a href="#">English</a><ul class="sub-menu submenu-languages"><li><a href="/es/access/" class="es" title="Español">Español</a></li></ul></li></ul></div></div></nav><header id="home-header" class="category-header"><div class="header-content"><div class="header-content-inner"><h2>Access to medicines</h2><p>A journalistic investigation into the issues limiting access to medicines around the world, country differences, the patent system and its alternatives.</p></div></div></header><section id="home" class="no-padding category-home"><div class="container-fluid"><div class="row no-gutter"><div class="col-sm-12"><a class="portfolio-box portfolio-prices category-access" href="/access/prices/" title="Prices"><div class="portfolio-box-background" style="background-image: url('/assets/images/articles/viz-screenshoot-1040x456.jpg')"></div><div class="portfolio-box-overlay"></div><div class="portfolio-box-caption"><div class="portfolio-box-caption-content"><h3>Prices</h3><div class="portfolio-box-caption-description">14 medicines, 61 countries. Compare and analyse the differences between them</div><button class="read-more-btn btn">Explore the data</button></div></div></a></div><div class="col-sm-12"><a class="portfolio-box portfolio-counterfeits category-access" href="/access/counterfeits/" title="Counterfeits"><div class="portfolio-box-background" style="background-image: url('/assets/images/articles/home-falsificaciones-1040x694.jpg')"></div><div class="portfolio-box-overlay"></div><div class="portfolio-box-caption"><div class="portfolio-box-caption-content"><h3>Counterfeits</h3><div class="portfolio-box-caption-description">The high prices of medicines, especially on developing coutries, open the door to an illegal market of dangerous counterfeits</div><button class="read-more-btn btn">Read more</button></div></div></a></div><div class="col-sm-12"><a class="portfolio-box portfolio-compulsory-license category-access" href="/access/compulsory-license/" title="Compulsory license"><div class="portfolio-box-background" style="background-image: url('/assets/images/articles/home-brasil-1040x694.jpg')"></div><div class="portfolio-box-overlay"></div><div class="portfolio-box-caption"><div class="portfolio-box-caption-content"><h3>Compulsory license</h3><div class="portfolio-box-caption-description">Eight years after overthrowing an antiretroviral patent, new doubts arise about the sustainability of the Brazilian government’s AIDS programme</div><button class="read-more-btn btn">Read more</button></div></div></a></div><div class="col-sm-12"><a class="portfolio-box portfolio-patents category-access" href="/access/patents/" title="Patents"><div class="portfolio-box-background" style="background-image: url('/assets/images/articles/home-patentes-1040x694.jpg')"></div><div class="portfolio-box-overlay"></div><div class="portfolio-box-caption"><div class="portfolio-box-caption-content"><h3>Patents</h3><div class="portfolio-box-caption-description">Although there are alternative models, the use of intellectual property rights, as applied to medicine, remains mandatory for the industry</div><button class="read-more-btn btn">Read more</button></div></div></a></div><div class="col-sm-12"><a class="portfolio-box portfolio-access-team category-access" href="/access/team/" title="Team and methodology"><div class="portfolio-box-background" style="background-image: url('/assets/images/pages/nosotros-1040x552.jpg')"></div><div class="portfolio-box-overlay"></div><div class="portfolio-box-caption"><div class="portfolio-box-caption-content"><h3>Team and methodology</h3><div class="portfolio-box-caption-description"></div><button class="read-more-btn btn">Read more</button></div></div></a></div></div></div></section><section class="no-padding" id="key-findings"><div class="key-findings-overlay"></div><div class="container"><h3>Key Findings</h3><ul><li><a href="http://medicamentalia.org/en/prices/" title="Prices - Medicamentalia">The differences in price of 14 drugs analysed in 61 countries are very pronounced <strong>even when looking at generics</strong>. And the variance is not compensated by salaries. This means that a citizen of a developing country has to work much harder to afford the same treatment.</a></li><li><a href="http://medicamentalia.org/en/prices/#viz" title="Prices - Medicamentalia">In Nigeria or Congo, buying <strong>a box of 30 omeprazole pills costs 13 days’ wages, while it’s between one and two hours of wages in Spain, Germany and Italy</strong>. The most expensive drug in all the countries analysed was <strong>simvastatin</strong> (almost five days’ wages on average) against less than one hour’s for diazepam.</a></li><li><a href="http://medicamentalia.org/en/counterfeits/" title="Counterfeits - Medicamentalia">In Ghana, we showed that there is a relationship between the high price of highly demanded essential medicines and their counterfeits, illegally imported from Asia.</a></li><li><a href="http://medicamentalia.org/en/patents/#the-cost-of-developing-a-new-drug" title="Patents - Medicamentalia">The costs of creating a new drug are <strong>not transparent</strong>. Studies supported by the pharmaceutical industry talk of 2.277 billion euros, while civil society organisations claim that 44 million euros are enough. It’s <strong>impossible to have a facts-based debate with the current data</strong>.</a></li><li><a href="http://medicamentalia.org/en/patents/#alternatives" title="Patents - Medicamentalia">A number of initiatives pushed forward by public and private organisations, such as as PDP, are looking for <strong>alternative models to intellectual property</strong>. Although the industry acknowledges the benefits of these procedures in some particular cases, it argues that <strong>the patent system is non-negotiable</strong>.</a></li><li><a href="http://medicamentalia.org/en/compulsory-license/" title="Compulsory License - Medicamentalia">The approval of compulsory licensing in Brazil in 2007 <strong>didn’t make drug companies abandon the country, as was augured</strong> by certain companies in the sector and even some governments such as the United States’ one. Quite the opposite, both foreign investment and the number of patents have kept growing since then.</a></li></ul></div></section><div class="partners"><div class="container"><div class="row main-partners"><div class="col-sm-6"><p>Medicamentalia is a project by</p><a class="partner-logo" href="http://www.civio.es" target="_blank" title="Fundación Ciudadana Civio"><img src="/assets/images/logo-civio.png" alt="Fundación Ciudadana Civio"></a></div><div class="col-sm-6"><p>Funded by</p><a class="partner-logo" href="http://journalismgrants.org/projects/medicamentalia" target="_blank" title="Journalism Grants"><img src="/assets/images/logo-journalismgrants.png" alt="Journalism Grants"></a></div><div class="col-sm-12"><hr></div></div><p>Has media partners such as</p><div class="media-partner"><a href="http://www.20minutos.es/" class="logo" target="_blank" title="20Minutos"><img class="img-responsive" src="/assets/images/logo-20minutos.png" alt="20Minutos"></a></div><div class="media-partner"><a href="http://cadenaser.com/" class="logo" target="_blank" title="Cadena SER"><img class="img-responsive" src="/assets/images/logo-cadenaser.png" alt="Cadena SER"></a></div><div class="media-partner"><a href="https://correctiv.org/" class="logo" target="_blank" title="Correctiv"><img class="img-responsive" src="/assets/images/logo-correctiv.png" alt="Correctiv"></a></div><div class="media-partner"><a href="http://www.lanacion.com.ar/" class="logo" target="_blank" title="La Nación"><img class="img-responsive" src="/assets/images/logo-lanacion.png" alt="La Nación"></a></div><div class="media-partner"><a href="http://www.knack.be/" class="logo" target="_blank" title="Knack"><img class="img-responsive" src="/assets/images/logo-knack.png" alt="Knack"></a></div><div class="row"><div class="col-sm-12"><hr></div></div><div class="row awards"><p>Awards</p><div class="col-sm-6 col-md-4 col-md-offset-2"><a href="http://premioggm.org/2016/09/estos-son-los-ganadores-del-premio-gabo-2016/" class="logo" target="_blank" title="Premio Gabriel García Márquez"><img class="img-responsive" src="/assets/images/award-ggm.png" alt="Premio Gabriel García Márquez"></a></div><div class="col-sm-6 col-md-4"><a href="http://www.globaleditorsnetwork.org/programmes/data-journalism-awards/" class="logo" target="_blank" title="Data Journalism Awards 2016"><img class="img-responsive" src="/assets/images/award-dja.png" alt="Data Journalism Awards 2016"></a></div></div><div class="row finalists"><p>Finalist in</p><div class="col-sm-4 col-sm-offset-2 col-md-3 col-md-offset-3"><a href="http://www.europeanpressprize.com/winners/year-2016/the-innovation-award/" class="logo" target="_blank" title="European Press Prize"><img class="img-responsive" src="/assets/images/award-epp.png" alt="European Press Prize"></a></div><div class="col-sm-4 col-md-3"><a href="http://www.dig-awards.org/awards/data-journalism/" class="logo" target="_blank" title="DIG Awards 2016"><img class="img-responsive" src="/assets/images/award-dig.png" alt="DIG Awards 2016"></a></div><div class="col-sm-12"><hr></div></div><div class="row"><div class="col-md-8 col-md-offset-2"><p>If you want more information, subscribe to our newsletter or contact us at <a href="mailto:contacto@civio.es">contacto@civio.es</a></p><form target="_blank" class="validate" name="mc-embedded-subscribe-form" id="mc-embedded-subscribe-form" method="post" action="http://civio.us4.list-manage1.com/subscribe/post?u=9416fe6b76f2c3f985c1f8e0f&amp;id=9d5b4c8cda"><input id="mce-EMAIL" class="email" type="email" required="" placeholder="correo" name="EMAIL" value="SUBSCRIBE TO OUR NEWSLETTER "> <button type="submit" id="btn-newsletter-header" class="btn btn-submit"><i class="glyphicon glyphicon-chevron-right"></i><span>Send</span></button></form></div></div></div></div><footer class="footer"><div class="container"><p>© <time datetime="2015-05-22T10:41:19+02:00">2015</time> · <a href="http://civio.es" target="_blank" title="Fundación Ciudadana Civio">Fundación Ciudadana Civio</a> <small><a href="https://creativecommons.org/licenses/by/3.0/" target="_blank" title="Creative Commons - Attribution 3.0 Unported - CC BY 3.0">(CC-BY 3.0)</a></small></p></div></footer><script type="text/javascript" src="/assets/scripts/main.js"></script><script>(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-28946840-11', 'auto');
  ga('send', 'pageview');</script></body></html>